Amid restructuring efforts, Bayer has addressed its need for a capital infusion in pharma under a deal to secure 3 billion euros ($3.4 billion) in equity from New York City asset manager Apollo, ...

Bayer has picked a fight with some of its most important customers: U.S. farmers. The German multinational pharmaceutical and biotechnology company isn't supplying them aspirin—they're a lead company ...

Discover powerful machines designed to remove fallen trees quickly and efficiently making forestry work and storm cleanup safer faster and more productive with advanced equipment built for demanding ...

Hyderabad: To ensure safer, faster and environmentally friendly tree trimming operations near power lines, TGSPDCL has introduced advanced battery-powered professional tree pruners into its field ...

Wall Street's major indexes ended lower on Friday as the technology sector continued its selloff after mounting concerns over elevated AI-related valuations and OpenAI considering pausing its IPO ...

The Supreme Court in a 7-2 decision on Thursday said Bayer cannot be sued over state-level claims that the company failed to warn of cancer risks from its weedkiller Roundup and its chemical ...

Following its 2018 acquisition of Monsanto, Bayer has spent years defending tens of thousands of lawsuits alleging that Roundup weed killer causes cancer and has incurred billions of dollars in ...

Phase II ARACOG (AFT-47) head-to-head trial met its primary endpoint, with patients treated with NUBEQA® (darolutamide) showing a decline in maximally changed cognitive domain (MCCD) by 24 weeks, with ...

Less than 48 hours after Crystal Palace’s UEFA Conference League triumph, Bayer Leverkusen will hold a meeting with Oliver Glasner as their search for a new head coach continues. It comes after die ...

CHICAGO, May 27 (Reuters) - Bayer (BAYGn.DE), opens new tab used illegal and anti-competitive practices to monopolize the U.S. market for genetically engineered corn seeds, reaping "hundreds of ...

“Secondary stroke remains a serious and persistent challenge, and the FDA’s Priority Review designation underscores the urgency of advancing potential new approaches in secondary stroke prevention,” ...